XNAS: INKT
MiNK Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated disea...
Read More
10.51
-0.54
(-4.89%)
64,804
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for MiNK Therapeutics Inc is on 15 May 2026 for the purpose of MiNK Therapeutics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
MiNK Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..